Here are four observations:
1. StemCells is searching for patients with cervical spinal cord injuries that caused full paralysis of the legs and partial paralysis of the arms, to participate in the Phase II trial.
2. StemCells reported seven of 12 patients with thoracic spinal cord injuries who received the stem-cell procedure regained sensation below the injury level.
3. A Phase I trial saw five quadriplegic patients with cervical spinal cord injuries regain upper-body strength.
4. StemCells is hopeful for FDA approval in the future if the clinical trials continue to demonstrate positive outcomes.
More articles on spine:
5 key notes on ocular radiation exposure during minimally invasive spine surgery
Dr. Fred Sweet serves visiting professor to University of Pennsylvania — 5 observations
The race to the White House: Spine surgeons weigh in on candidates’ healthcare strategy
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.